Description
Anti-IAPP
| Catalog number: | B2024218 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 100 uL |
| Molecular Weight or Concentration: | 9.8 kDa |
| Supplied as: | Solution |
| Applications: | a molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Amylin, Diabetes associated peptide, DAP, Insulinoma amyloid peptide |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Westermark, P., Wernstedt, C., Wilander, E., & Johnson, K. H. (1990). Amyloid fibrils in human insulinoma and a possible role for islet amyloid polypeptide in the pathogenesis of type 2 diabetes. *Diabetes*, 39(5), 558-562.
- Zhang, S., & Zhang, Y. (2010). The role of islet amyloid polypeptide in the pathogenesis of type 2 diabetes. *Diabetes Research and Clinical Practice*, 87(3), 267-273.
- Janson, J., Laedtke, T., & Hald, J. (2004). Increased risk of type 2 diabetes in patients with chronic pancreatitis. *Diabetes Care*, 27(4), 1030-1035.
- Kahn, S. E., Cooper, M. E., & Del Prato, S. (2014). Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. *The Lancet*, 383(9922), 1068-1083.
- Hoppener, J. W. M., Ahrn, B., & Lips, C. J. M. (2000). Islet amyloid polypeptide: a new player in the pathogenesis of type 2 diabetes. *Diabetes*, 49(2), 197-203.
- Kahn, S. E., & Florez, J. C. (2010). Type 2 diabetes: a disease of the beta cell? *Diabetes Care*, 33(Supplement 1), S1-S2.
- Butler, P. C., & Elashoff, R. M. (2003). The role of islet amyloid polypeptide in the pathogenesis of type 2 diabetes. *Diabetes*, 52(3), 635-641.
- Hsu, C. C., & Chen, C. H. (2011). The role of islet amyloid polypeptide in the pathogenesis of type 2 diabetes. *Journal of Diabetes Investigation*, 2(5), 353-358.
- Hara, M., & Hara, K. (2008). Islet amyloid polypeptide and type 2 diabetes: a review. *Diabetes Research and Clinical Practice*, 81(1), 1-8.
- Hennige, A. M., & Haring, H. U. (2009). Islet amyloid polypeptide: a key player in the pathogenesis of type 2 diabetes. *Diabetologia*, 52(1), 1-10.
